$CRDF
Cardiff Oncology, Inc. Stock $crdf

$crdf Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000110465914020261 Filed on March 17, 2014

Income Statement

Concept	2013 Q4	2013 Q3	2013 Q2
Revenue	$47.00K	$44.00K	$49.00K
YoY Change	-71.17%	-79.25%	16.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.860M	$2.210M	$1.480M
YoY Change	86.0%	198.65%	82.72%
% of Gross Profit
Research & Development	$1.040M	$915.5K	$940.0K
YoY Change	76.27%	79.0%	95.83%
% of Gross Profit
Depreciation & Amortization	$40.00K	$50.00K	$20.00K
YoY Change	300.0%	150.0%
% of Gross Profit
Operating Expenses	$2.900M	$915.5K	$2.420M
YoY Change	81.25%	79.0%	87.6%
Operating Profit		-$3.078M
YoY Change		196.22%
Interest Expense	$1.840M	$6.263K	-$2.900M
YoY Change	-137.55%	-98.39%	33.03%
% of Operating Profit
Other Income/Expense, Net		$0.00
YoY Change
Pretax Income	-$1.030M	-$4.400M	-$5.270M
YoY Change	-83.73%	576.92%	53.64%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$1.030M	-$4.401M	-$5.270M
YoY Change	-83.73%	576.88%	53.81%
Net Earnings / Revenue	-2191.49%	-10002.8%	-10755.1%
Basic Earnings Per Share
Diluted Earnings Per Share	-$3.962M	-$17.60M	-$20.27M
COMMON SHARES
Basic Shares Outstanding	18.90M shares	18.85M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q4	2013 Q3	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.80M	$27.80M	$8.300M
YoY Change	138.89%	256.41%	-10.75%
Cash & Equivalents	$25.84M	$27.80M	$8.302M
Short-Term Investments
Other Short-Term Assets	$200.0K	$100.0K	$200.0K
YoY Change	100.0%	0.0%
Inventory
Prepaid Expenses
Receivables	$78.99K	$69.57K	$100.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$26.07M	$28.00M	$8.524M
YoY Change	135.95%	249.95%	-9.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$750.6K	$740.3K	$600.0K
YoY Change	194.64%	255.25%	500.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$336.5K	$411.9K	$500.0K
YoY Change	-7.08%	13.76%	25.0%
Total Long-Term Assets	$1.087M	$1.152M	$1.102M
YoY Change	76.23%	101.98%	99.65%
TOTAL ASSETS
Total Short-Term Assets	$26.07M	$28.00M	$8.524M
Total Long-Term Assets	$1.087M	$1.152M	$1.102M
Total Assets	$27.16M	$29.15M	$9.625M
YoY Change	132.8%	240.11%	-3.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$286.6K	$159.0K	$300.0K
YoY Change	63.14%	13.53%	-40.0%
Accrued Expenses	$1.524M	$1.054M	$1.100M
YoY Change	174.76%	70.7%	57.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$200.0K	$100.0K	$100.0K
YoY Change
Total Short-Term Liabilities	$2.009M	$1.361M	$1.462M
YoY Change	175.05%	79.62%	21.85%
LONG-TERM LIABILITIES
Long-Term Debt	$300.0K	$400.0K	$300.0K
YoY Change
Other Long-Term Liabilities	$4.400M	$6.300M	$10.40M
YoY Change	-50.0%	125.0%	225.0%
Total Long-Term Liabilities	$4.700M	$6.700M	$10.70M
YoY Change	-46.59%	139.29%	234.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.009M	$1.361M	$1.462M
Total Long-Term Liabilities	$4.700M	$6.700M	$10.70M
Total Liabilities	$6.764M	$8.012M	$12.10M
YoY Change	-28.77%	122.84%	171.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$67.04M	-$66.01M
YoY Change	21.45%	35.07%
Common Stock	$1.890K	$1.889K
YoY Change	22.17%	33.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.39M	$21.14M	-$2.471M
YoY Change
Total Liabilities & Shareholders Equity	$27.16M	$29.15M	$9.600M
YoY Change	132.8%	240.11%	-4.0%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2013 Q2
OPERATING ACTIVITIES
Net Income	-$1.030M	-$4.401M	-$5.270M
YoY Change	-83.73%	576.88%	53.81%
Depreciation, Depletion And Amortization	$40.00K	$50.00K	$20.00K
YoY Change	300.0%	150.0%
Cash From Operating Activities	-$1.860M	-$2.100M	-$1.730M
YoY Change	41.98%	47.89%	34.11%
INVESTING ACTIVITIES
Capital Expenditures	-$80.00K	-$210.0K	-$270.0K
YoY Change	33.33%	200.0%	575.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$80.00K	-$210.0K	-$270.0K
YoY Change	33.33%	200.0%	575.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.00K	21.80M	1.140M
YoY Change	-100.69%		-88.67%
NET CHANGE
Cash From Operating Activities	-1.860M	-2.100M	-1.730M
Cash From Investing Activities	-80.00K	-210.0K	-270.0K
Cash From Financing Activities	-30.00K	21.80M	1.140M
Net Change In Cash	-1.970M	19.49M	-860.0K
YoY Change	-165.67%	-1408.05%	-109.85%
FREE CASH FLOW
Cash From Operating Activities	-$1.860M	-$2.100M	-$1.730M
Capital Expenditures	-$80.00K	-$210.0K	-$270.0K
Free Cash Flow	-$1.780M	-$1.890M	-$1.460M
YoY Change	42.4%	40.0%	16.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	168381	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	60041	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1979364	USD
CY2013	trov	Value Of Warrants Issued During Period For Cash Consideration ValueOfWarrantsIssuedDuringPeriodForCashConsideration	3599831	USD
CY2013	us-gaap	Dividends Preferred Stock DividendsPreferredStock	29840	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	Trovagene, Inc.
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001213037
CY2003	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	0.003
CY2005	trov	Issuance Of Common Stock And Warrants For Cash Price Per Unit IssuanceOfCommonStockAndWarrantsForCashPricePerUnit	11.70
CY2007	trov	Issuance Of Common Stock And Warrants For Cash Price Per Unit IssuanceOfCommonStockAndWarrantsForCashPricePerUnit	6.00
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	dei	Entity Public Float EntityPublicFloat	100377714	USD
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18902991	shares
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2005	trov	Number Of Warrants Issued During Period For Noncash Consideration NumberOfWarrantsIssuedDuringPeriodForNoncashConsideration	20610	shares
CY2007	trov	Number Of Warrants Issued During Period For Noncash Consideration NumberOfWarrantsIssuedDuringPeriodForNoncashConsideration	15779	shares
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10819781	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	11048203	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	362081	USD
CY2006	trov	Issuance Of Preferred Stock And Warrants For Cash Per Share IssuanceOfPreferredStockAndWarrantsForCashPerShare	10.00
CY2011Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2007Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2012Q4	us-gaap	Assets Assets	11665026	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	175679	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	554691	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	198166	USD
CY2012Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	730370	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	322998	USD
CY2012Q4	us-gaap	Liabilities Liabilities	9495998	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	96	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	1547	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57370017	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55202632	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11665026	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27155735	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	20392000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	6763735	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2008866	USD
CY2013Q4	us-gaap	Assets Assets	27155735	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	26068720	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	60600	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	95600	shares
CY2013Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	606000	USD
CY2012Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	956000	USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18902782	shares
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7317248	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4934661	USD
CY2013	us-gaap	Royalty Revenue RoyaltyRevenue	259246	USD
CY2012	us-gaap	Royalty Revenue RoyaltyRevenue	175404	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2335050	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	297104	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	8765628	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4431871	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10584153	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10795956	shares
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1099167	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	514383	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	750565	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	254742	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Use of Estimates</font></i></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div>
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Concentration of credit risk</font></i></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company maintains its cash in financial institutions, which at times may exceed the amount insured by the Federal Deposit Insurance Corporation (“FDIC”). All of the Company’s noninterest bearing cash balances were insured up to $250,000 at December 31, 2013 and fully insured at December 31, 2012 due to a temporary federal program in effect through December 31, 2012.</font></p> </div>
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10913700	USD
CY2012Q4	trov	Deferred Tax Assets Tax Credit Carryforwards Research And Other DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther	123300	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	723900	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	65000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	11825900	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	11825900	USD
CY2013Q4	trov	Income Tax Potential Estimated Exposure IncomeTaxPotentialEstimatedExposure	40000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14211400	USD
CY2013Q4	trov	Deferred Tax Assets Tax Credit Carryforwards Research And Other DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther	235300	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1547500	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	230400	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	16224600	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	16224600	USD
CY2011	us-gaap	Royalty Revenue RoyaltyRevenue	227696	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1184720	USD
CY2012	us-gaap	Revenue Recognition Milestone Method Revenue Recognized RevenueRecognitionMilestoneMethodRevenueRecognized	150000	USD
	us-gaap	Revenue Recognition Milestone Method Revenue Recognized RevenueRecognitionMilestoneMethodRevenueRecognized	150000	USD
CY2012	us-gaap	License And Services Revenue LicenseAndServicesRevenue	125000	USD
CY2011	us-gaap	License And Services Revenue LicenseAndServicesRevenue	30000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	1383175	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	259246	USD
CY2005	trov	Share Exchange During Period With Founder ShareExchangeDuringPeriodWithFounder	0	USD
CY2005	trov	Treasury Shares Issued Value TreasurySharesIssuedValue	0	USD
CY2005	trov	Treasury Stock Issued To Escrow Value TreasuryStockIssuedToEscrowValue	0	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	164000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-4231268	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	2169028	USD
CY2000Q1	us-gaap	Stockholders Equity StockholdersEquity	27240	USD
CY2001Q1	us-gaap	Stockholders Equity StockholdersEquity	-240359	USD
CY2002Q1	us-gaap	Stockholders Equity StockholdersEquity	-719395	USD
CY2004Q1	us-gaap	Stockholders Equity StockholdersEquity	-1578125	USD
CY2007Q1	us-gaap	Stockholders Equity StockholdersEquity	1129659	USD
CY2005Q1	us-gaap	Stockholders Equity StockholdersEquity	3190935	USD
CY2006Q1	us-gaap	Stockholders Equity StockholdersEquity	3480710	USD
CY2007Q4	us-gaap	Stockholders Equity StockholdersEquity	-1645793	USD
CY2003	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	3400	USD
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18902782	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15478177	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15478177	shares
CY2008	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	1145000	USD
CY2009	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	1465000	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	-4047807	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	-3786709	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-4995365	USD
CY2002	trov	Adjustment To Additional Paid In Capital For Capital Contribution By Stockholders AdjustmentToAdditionalPaidInCapitalForCapitalContributionByStockholders	45188	USD
CY2005	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	500000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	5299560	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	3234499	USD
	us-gaap	Costs And Expenses CostsAndExpenses	56986223	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-10690541	USD
CY2007	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	9566	USD
CY2006	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	16500	USD
CY2003	trov	Adjustment To Additional Paid In Capital For Capital Contribution By Stockholders AdjustmentToAdditionalPaidInCapitalForCapitalContributionByStockholders	2500	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	450404	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	257696	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	2717895	USD
CY2013	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	3947589	USD
CY2012	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1920298	USD
CY2011	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	910685	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	21397040	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130520	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7002198	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3379262	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2323814	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32922314	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	10949787	USD
CY2005	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	301499	USD
CY2012	trov	Adjustments To Additional Paid In Capital Warrants Reclassified Amount AdjustmentsToAdditionalPaidInCapitalWarrantsReclassifiedAmount	3317463	USD
CY2008	trov	Warrants Classified As Derivative Liabilities WarrantsClassifiedAsDerivativeLiabilities	201122	USD
CY2006	trov	Warrants Classified As Derivative Liabilities WarrantsClassifiedAsDerivativeLiabilities	567085	USD
CY2006	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2928298	USD
CY2007	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1572545	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	914847	USD
CY2008	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	543697	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	177836	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	325930	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	250978	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	532140	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	600	USD
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	200	shares
CY2013	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	29840	USD
CY2012	trov	Stock Issued During Period Shares Warrants Exercised Net StockIssuedDuringPeriodSharesWarrantsExercisedNet	8602	shares
CY2005	trov	Amortization Of Deferred Stock Based Compensation Expense AmortizationOfDeferredStockBasedCompensationExpense	245697	USD
CY2006	trov	Amortization Of Deferred Stock Based Compensation Expense AmortizationOfDeferredStockBasedCompensationExpense	645832	USD
CY2005	trov	Adjustment To Additional Paid In Capital For Options Issued To Consultants AdjustmentToAdditionalPaidInCapitalForOptionsIssuedToConsultants	1229568	USD
CY2011	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	2335050	USD
CY2008	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	93641	USD
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1130164	USD
CY2012	trov	Stock Issuance Costs Adjustment To Equity StockIssuanceCostsAdjustmentToEquity	1576452	USD
CY2006	us-gaap	Dividends Preferred Stock DividendsPreferredStock	60741	USD
CY2007	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59164	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	35054	USD
CY2008	us-gaap	Dividends Preferred Stock DividendsPreferredStock	38240	USD
CY2009	us-gaap	Dividends Preferred Stock DividendsPreferredStock	38240	USD
CY2010	us-gaap	Dividends Preferred Stock DividendsPreferredStock	38240	USD
CY2011	us-gaap	Dividends Preferred Stock DividendsPreferredStock	38240	USD
CY2012	us-gaap	Dividends Preferred Stock DividendsPreferredStock	38240	USD
CY2008	trov	Stock Issued During Period Value Reclassification Of Temporary Equity StockIssuedDuringPeriodValueReclassificationOfTemporaryEquity	905000	USD
CY2007	trov	Reclassification Of Derivative Financial Instruments Adoption Of Pronouncement ReclassificationOfDerivativeFinancialInstrumentsAdoptionOfPronouncement	111700	USD
CY2012	trov	Reclassification Of Derivative Financial Instruments Correction Of Error ReclassificationOfDerivativeFinancialInstrumentsCorrectionOfError	274967	USD
CY2009	trov	Warrants And Price Protected Units Classified As Derivative Liabilities Value WarrantsAndPriceProtectedUnitsClassifiedAsDerivativeLiabilitiesValue	1497568	USD
CY2010	trov	Warrants And Price Protected Units Classified As Derivative Liabilities Value WarrantsAndPriceProtectedUnitsClassifiedAsDerivativeLiabilitiesValue	1010114	USD
CY2011	trov	Warrants And Price Protected Units Classified As Derivative Liabilities Value WarrantsAndPriceProtectedUnitsClassifiedAsDerivativeLiabilitiesValue	1298618	USD
CY2012	trov	Warrants And Price Protected Units Classified As Derivative Liabilities Value WarrantsAndPriceProtectedUnitsClassifiedAsDerivativeLiabilitiesValue	1796610	USD
CY2007	trov	Adjustment To Additional Paid In Capital For Donated Services AdjustmentToAdditionalPaidInCapitalForDonatedServices	62500	USD
	trov	Adjustment To Additional Paid In Capital For Donated Services AdjustmentToAdditionalPaidInCapitalForDonatedServices	275000	USD
CY2008	trov	Adjustment To Additional Paid In Capital For Donated Services AdjustmentToAdditionalPaidInCapitalForDonatedServices	390750	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-4849156	USD
CY2003	us-gaap	Net Income Loss NetIncomeLoss	-481609	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14760	USD
CY2001	us-gaap	Net Income Loss NetIncomeLoss	-267599	USD
CY2002	us-gaap	Net Income Loss NetIncomeLoss	-524224	USD
CY2004	us-gaap	Net Income Loss NetIncomeLoss	-383021	USD
CY2005	us-gaap	Net Income Loss NetIncomeLoss	-5371027	USD
CY2006	us-gaap	Net Income Loss NetIncomeLoss	-7844326	USD
CY2007	us-gaap	Net Income Loss NetIncomeLoss	-7134067	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4683141	USD
CY2008	us-gaap	Net Income Loss NetIncomeLoss	-5166240	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	-2483807	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-5449138	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-2976803	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18829644	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	227541	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	230584	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	237339	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	250855	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	946319	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	294000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	270000	USD
CY2013	trov	Defined Contribution Plan Threshold Age Catch Up Contribution DefinedContributionPlanThresholdAgeCatchUpContribution	P55Y
CY2006Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2000000	shares
CY2006Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	833333	shares
CY2009Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	3666667	shares
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	532140	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1979364	USD
CY2004Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	111	pure
CY2012Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1667	pure
CY2012	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	16667	shares
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.00
CY2011Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3601474	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6233483	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6985070	shares
CY2013	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	50000	shares
CY2012	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	3416934	shares
CY2013	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	728488	shares
CY2013	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	73099	shares
CY2012	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	16671	shares
CY2013Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.87
CY2011Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.18
CY2012Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.96
CY2013	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	8.00
CY2012	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	4.88
CY2012	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	3.00
CY2013	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	4.50
CY2012	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	3.00
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18829644	USD
	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Income NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetIncome	-455385	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	250978	USD
CY2011	trov	Unrealized Gain Loss On Modification Of Warrants UnrealizedGainLossOnModificationOfWarrants	-581503	USD
CY2011	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	38240	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	41842	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10285	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	394161	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	1979364	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	532140	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	250978	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13991829	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-54268328	USD
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	3663	USD
	trov	Founders Compensation Contributed To Equity FoundersCompensationContributedToEquity	1655031	USD
	trov	Donated Services Contributed To Equity DonatedServicesContributedToEquity	829381	USD
	trov	Settlement Of Consulting Services In Stock SettlementOfConsultingServicesInStock	478890	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2346330	USD
	trov	Stock Based Liquidated Damages And Forbearance Settlement Costs StockBasedLiquidatedDamagesAndForbearanceSettlementCosts	1758111	USD
CY2011	us-gaap	Paid In Kind Interest PaidInKindInterest	56636	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	104700	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	270080	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-270080	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1268367	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15323548	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2573500	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	51585195	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3599831	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3599831	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	38249	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	38849	USD
	trov	Proceeds From Non Exclusive Selling Agent Agreement ProceedsFromNonExclusiveSellingAgentAgreement	142187	USD
CY2013	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	515964	USD
	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	515964	USD
	trov	Payment For Recapitalization Cost PaymentForRecapitalizationCost	-362849	USD
CY2012	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	10119407	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	25836937	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	757198	USD
CY2013	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1084114	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2771000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	277102	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25836937	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	700374	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	7650	USD
CY2013	us-gaap	Interest Paid InterestPaid	9459	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1130164	USD
	trov	Adjustments To Additional Paid In Capital Warrants Reclassified Amount AdjustmentsToAdditionalPaidInCapitalWarrantsReclassifiedAmount	8735334	USD
	trov	Reclassification Of Derivative Financial Instruments Correction Of Error ReclassificationOfDerivativeFinancialInstrumentsCorrectionOfError	274967	USD
CY2011	us-gaap	Investment Income Net InvestmentIncomeNet	171	USD
CY2012	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	38240	USD
	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	221040	USD
CY2011	trov	Interest Paid In Common Stock InterestPaidInCommonStock	128421	USD
	trov	Interest Paid In Common Stock InterestPaidInCommonStock	1325372	USD
	us-gaap	Stock Issued During Period Shares Issued For Noncash Consideration StockIssuedDuringPeriodSharesIssuedForNoncashConsideration	41750	shares
CY2013	us-gaap	Interest Expense InterestExpense	17005	USD
CY2011	us-gaap	Interest Expense InterestExpense	56636	USD
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	41667	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.50
	us-gaap	Interest Expense InterestExpense	1342377	USD
CY2013	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	4.99
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22941	USD
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	2335050	USD
CY2013Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	198166	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	209032	USD
CY2013Q4	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	113966	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	270546	USD
CY2005	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	0	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	92748	USD
CY2012	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	17383	USD
CY2011	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-108374	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	152789	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1055690	USD
CY2013	trov	Adjustments To Additional Paid In Capital Warrants Reclassified Amount AdjustmentsToAdditionalPaidInCapitalWarrantsReclassifiedAmount	5417871	USD
CY2013	trov	Adjustment To Additional Paid In Capital For Warrants Issued As Noncash Consideration AdjustmentToAdditionalPaidInCapitalForWarrantsIssuedAsNoncashConsideration	198791	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4000	USD
CY2012	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-6720805	USD
CY2013	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	0	USD
CY2013	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6127249	shares
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78994	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	152789	USD
CY2011	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	170673	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	336450	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	286608	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1524092	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	1890	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	87433460	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67043410	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-18941	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2346330	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-6578913	USD
CY2011	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	623383	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	623383	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	2666869	USD
	trov	Liquidated Damages And Other Forbearance Costs LiquidatedDamagesAndOtherForbearanceCosts	1758111	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-11810938	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-11565961	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-2239212	USD
	us-gaap	Net Income Loss NetIncomeLoss	-65419071	USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	29840	USD
CY2012	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	38240	USD
CY2011	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	38240	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	375998	USD
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	792956	USD
	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Income NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetIncome	-455385	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11840778	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11604201	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2277452	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-67043410	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.89
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16978212	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13066600	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9711519	shares
	trov	Stock Based Expense For Severance Pay StockBasedExpenseForSeverancePay	28346	USD
	trov	Stock Based Expense For Legal Fees StockBasedExpenseForLegalFees	100000	USD
CY2012	trov	Stock Based Expense For Consulting Services StockBasedExpenseForConsultingServices	164889	USD
CY2011	trov	Stock Based Expense For Consulting Services StockBasedExpenseForConsultingServices	175000	USD
	trov	Stock Based Expense For Consulting Services StockBasedExpenseForConsultingServices	651180	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-25631	USD
CY2011	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-21648	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	44250	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-89387	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	69241	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24140	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	78995	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	7650	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-737752	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1734309	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1930301	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-32328999	USD
	us-gaap	Interest Paid InterestPaid	9459	USD
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1172000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2012Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11001679	shares
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	649284	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1528	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1163667	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-649284	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1528	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	500000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	116718	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	22983688	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	15324148	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2573500	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	59434303	USD
CY2013	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	15017156	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	641671	USD
CY2013Q4	trov	Noninterest Bearing Cash Balance Fdic Insured Amount Maximum NoninterestBearingCashBalanceFDICInsuredAmountMaximum	250000	USD
CY2013Q4	us-gaap	Area Of Land AreaOfLand	8041
CY2013Q4	us-gaap	Area Of Land AreaOfLand	8303
CY2013	trov	Stock Issued During Period Value Stock Options Exercised Net StockIssuedDuringPeriodValueStockOptionsExercisedNet	38249	USD
CY2011	us-gaap	Stock Issued During Period Shares Issued For Noncash Consideration StockIssuedDuringPeriodSharesIssuedForNoncashConsideration	41750	shares
CY2013	us-gaap	License And Services Revenue LicenseAndServicesRevenue	0	USD
CY2013	us-gaap	Revenue Recognition Milestone Method Revenue Recognized RevenueRecognitionMilestoneMethodRevenueRecognized	0	USD
CY2011	us-gaap	Revenue Recognition Milestone Method Revenue Recognized RevenueRecognitionMilestoneMethodRevenueRecognized	0	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58703	USD
CY2010Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2629056	shares
CY2011	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	1048175	shares
CY2011	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	75757	shares
CY2010Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.24
CY2011	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	3.00
CY2011	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	4.50
CY2013	trov	Minimum Period Within Which Additional Capital Is Required To Be Raised MinimumPeriodWithinWhichAdditionalCapitalIsRequiredToBeRaised	P12M
CY2013	trov	Maximum Period Within Which Additional Capital Is Required To Be Raised MaximumPeriodWithinWhichAdditionalCapitalIsRequiredToBeRaised	P18M
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	119000	USD
CY2013Q1	us-gaap	Costs And Expenses CostsAndExpenses	2509000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1117000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	15510340	shares
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	49000	USD
CY2013Q2	us-gaap	Costs And Expenses CostsAndExpenses	2423000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5279000	USD
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	15583957	shares
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	44000	USD
CY2013Q3	us-gaap	Costs And Expenses CostsAndExpenses	3121000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4407000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17870703	shares
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	47000	USD
CY2013Q4	us-gaap	Costs And Expenses CostsAndExpenses	2897000	USD
CY2013Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1038000	USD
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2013Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18900781	shares
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	34000	USD
CY2012Q1	us-gaap	Costs And Expenses CostsAndExpenses	1164000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	42000	USD
CY2012Q2	us-gaap	Costs And Expenses CostsAndExpenses	1287000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3436000	USD
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12086528	shares
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	212000	USD
CY2012Q3	us-gaap	Costs And Expenses CostsAndExpenses	1250000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-660000	USD
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14178733	shares
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	163000	USD
CY2012Q4	us-gaap	Costs And Expenses CostsAndExpenses	1598000	USD
CY2012Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6336000	USD
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.43
CY2012Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14715668	shares
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	504186	USD
CY2013Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	521164	USD
CY2006	trov	Return Of Treasury Stock From Escrow During Period Value ReturnOfTreasuryStockFromEscrowDuringPeriodValue	0	USD
CY2006	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	0	USD
CY2007	trov	Reclassification Of Deferred Unamortized Stock Based Compensation ReclassificationOfDeferredUnamortizedStockBasedCompensation	0	USD
CY2013	trov	Stock Based Expense For Consulting Services StockBasedExpenseForConsultingServices	198791	USD
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00	pure
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4398700	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1992100	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	348602	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	259641	USD

Files In Submission

Name	View Source	Status
0001104659-14-020261-index-headers.html	Edgar Link	pending
0001104659-14-020261-index.html	Edgar Link	pending
0001104659-14-020261.txt	Edgar Link	pending
0001104659-14-020261-xbrl.zip	Edgar Link	pending
a13-26387_110k.htm	Edgar Link	pending
a13-26387_1ex21.htm	Edgar Link	pending
a13-26387_1ex23d1.htm	Edgar Link	pending
a13-26387_1ex31d1.htm	Edgar Link	pending
a13-26387_1ex31d2.htm	Edgar Link	pending
a13-26387_1ex32d1.htm	Edgar Link	pending
a13-26387_1ex32d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g263871bqi001.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trov-20131231.xml	Edgar Link	completed
trov-20131231.xsd	Edgar Link	pending
trov-20131231_cal.xml	Edgar Link	unprocessable
trov-20131231_def.xml	Edgar Link	unprocessable
trov-20131231_lab.xml	Edgar Link	unprocessable
trov-20131231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRDF
Cardiff Oncology, Inc. Stock $crdf

2013 Q4 Form 10-K Financial Statement

#000110465914020261 Filed on March 17, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF Cardiff Oncology, Inc. Stock $crdf

2013 Q4 Form 10-K Financial Statement

#000110465914020261 Filed on March 17, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF
Cardiff Oncology, Inc. Stock $crdf